Terns Pharmaceuticals Competitors and Similar CompaniesClear all
Terns Pharmaceuticals's competitors and similar companies include Fortrea.
 Terns Pharmaceuticals Terns Pharmaceuticals is a biopharmaceutical company developing small-molecule single-agent and combination therapy for the treatment of non-alcoholic steatohepatitis and other chronic liver diseases. |  Fortrea Fortrea Holdings (formerly known as Labcorp Clinical Development and Commercialization Services) is a contract research organization (CRO). | |
Founding Date | Founding Date 2017 | Founding Date 2023 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Foster City, US HQ | Locations Durham, US HQ Buenos Aires, AR Melbourne, AU Sydney, AU Zaventem, BE Sao Paulo, BR Sofia, BG see more |
Employees | Employees 59 | Employees 19,000 |
Valuation ($) | Valuation ($) 580.9 m | Valuation ($) 1.6 b |
Financial | ||
Net income | Net income ($96.2m) (FY, 2025) | Net income ($986.2m) (FY, 2025) |
For sources of this data, please see the company profile
View Company Profiles
Fortrea
HQ
Durham, US
Employees
19,000
Fortrea Holdings (formerly known as Labcorp Clinical Development and Commercialization Services) is a contract research organization (CRO).
View company